Cancer News and Research

Latest Cancer News and Research

UK researcher working to develop online tool to help patients navigate lung cancer screening decision

The phrase "we caught it early" is possibly the best news a patient can hear in the midst of a cancer diagnosis. Combating cancer in its earliest stages, when the disease is localized to a certain part of the body, gives patients the best chances of survival.

31 Jul 2014

Discovery could lead to development of new cancer therapies

DNA mutations-long known to fuel cancer as well as evolutionary changes in a living organism-had been thought to be rare events that occur randomly throughout the genome.

31 Jul 2014

El Camino Hospital uses Leaf Patient Monitoring system to help prevent hospital-acquired pressure ulcers

El Camino Hospital, a leader in the use of technology to improve patient care, is utilizing the Leaf Patient Monitoring system to help prevent hospital-acquired pressure ulcers by monitoring the position and movement of patients susceptible to bed sores.

30 Jul 2014

Glide Pharma licenses prostate cancer diagnostic technology from FScan

Glide Pharmaceutical Technologies Ltd today announced that it has taken an exclusive worldwide licence to an innovative prostate cancer diagnostic technology from FScan Ltd, a Durham University spin-out company.

30 Jul 2014

Researchers discover new function of body's most important tumor-suppressing protein

Researchers at Cold Spring Harbor Laboratory (CSHL) have discovered a new function of the body's most important tumor-suppressing protein. Called p53, this protein has been called "the guardian of the genome."

30 Jul 2014

Researchers develop vaccine against potentially deadly tick-transmitted disease

Virginia Commonwealth University School of Medicine researchers have made an important advancement toward developing a vaccine against the debilitating and potentially deadly tick-transmitted disease, human granulocytic anaplasmosis (HGA).

30 Jul 2014

EGPAF and ACS partner to improve access to essential pain medications for HIV people

Today the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) and the American Cancer Society (ACS) announced a new partnership to improve access to essential pain medications for people living with HIV in Swaziland.

30 Jul 2014

Researchers establish new strategy to help surgeons see entire tumor in patient

The best way to cure most cases of cancer is to surgically remove the tumor. The Achilles heel of this approach, however, is that the surgeon may fail to extract the entire tumor, leading to a local recurrence.

30 Jul 2014

Scientists show for the first time how structures inside cells are regulated

New research from scientists at the University of Kent has shown for the first time how the structures inside cells are regulated - a breakthrough that could have a major impact on cancer therapy development.

30 Jul 2014

Five-year $10.7M grant to study control, prevention of sexually-transmitted infections

The University of Maryland Schools of Dentistry (UM SOD) and Medicine (UM SOM) jointly announced today that they have received a five-year $10.7 million grant award from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health to study the causes, prevention and treatment of sexually-transmitted diseases (STDs).

30 Jul 2014

Researchers investigate hereditary breast cancer to find new treatment approaches

Deborah Kelly and Zhi Sheng, assistant professors at the Virginia Tech Carilion Research Institute, recently received a grant from the Commonwealth Health Research Board to investigate hereditary breast cancer, an effort that may lead to new treatment approaches.

30 Jul 2014

EMD Serono begins MSB0010718C Phase II study in mMCC patients

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, today announced the initiation of an international Phase II study designed to assess the efficacy and safety of MSB0010718C, an investigational fully human IgG1 monoclonal antibody that binds to programmed death-ligand 1 (PD-L1).

29 Jul 2014

FDA approves EYLEA Injection for treatment of Diabetic Macular Edema

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME).

29 Jul 2014

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.

29 Jul 2014

New stem-cell discovery may lead to more streamlined process for tissue regeneration

A new stem-cell discovery might one day lead to a more streamlined process for obtaining stem cells, which in turn could be used in the development of replacement tissue for failing body parts, according to UC San Francisco scientists who reported the findings in the current edition of Cell.

29 Jul 2014

Researchers find molecule that irreversibly interferes with activity of mutated cancer gene

UT Southwestern Medical Center cancer researchers have found a molecule that selectively and irreversibly interferes with the activity of a mutated cancer gene common in 30 percent of tumors.

29 Jul 2014

New pill-only antiviral drug regimens could cure hardest-to-treat hepatitis C

Two new pill-only antiviral drug regimens could provide shorter, more effective treatment options with fewer side effects for the majority of patients infected with hepatitis C, even those most difficult to treat, according to the results of two studies published in The Lancet.

29 Jul 2014

Healthy lifestyle may help childhood cancer survivors avoid metabolic syndrome

A new study has found that following a healthy lifestyle may lower childhood cancer survivors’ risk of developing the metabolic syndrome. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings indicate that children with cancer and adults who had cancer when they were children should receive information about how their lifestyle may influence their long-term health.

29 Jul 2014

EMA CHMP adopts positive opinion for Janssen’s IMBRUVICA to treat CLL and MCL

Janssen-Cilag International NV announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending the granting of a marketing authorisation for IMBRUVICA (ibrutinib) in the European Union.

29 Jul 2014

Viewpoints: GOP's 'political sideshow;' Boehner says House must defend the constitution; Jonathan Gruber on center stage about subsidies

This week, before the House leaves for its August recess, the GOP majority is expected to approve a lawsuit against Obama.

29 Jul 2014

Cancer News and Research

Latest Cancer News and Research

UK researcher working to develop online tool to help patients navigate lung cancer screening decision

Discovery could lead to development of new cancer therapies

El Camino Hospital uses Leaf Patient Monitoring system to help prevent hospital-acquired pressure ulcers

Glide Pharma licenses prostate cancer diagnostic technology from FScan

Researchers discover new function of body's most important tumor-suppressing protein

Researchers develop vaccine against potentially deadly tick-transmitted disease

EGPAF and ACS partner to improve access to essential pain medications for HIV people

Researchers establish new strategy to help surgeons see entire tumor in patient

Scientists show for the first time how structures inside cells are regulated

Five-year $10.7M grant to study control, prevention of sexually-transmitted infections

Researchers investigate hereditary breast cancer to find new treatment approaches

EMD Serono begins MSB0010718C Phase II study in mMCC patients

FDA approves EYLEA Injection for treatment of Diabetic Macular Edema

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

New stem-cell discovery may lead to more streamlined process for tissue regeneration

Researchers find molecule that irreversibly interferes with activity of mutated cancer gene

New pill-only antiviral drug regimens could cure hardest-to-treat hepatitis C

Healthy lifestyle may help childhood cancer survivors avoid metabolic syndrome

EMA CHMP adopts positive opinion for Janssen’s IMBRUVICA to treat CLL and MCL

Viewpoints: GOP's 'political sideshow;' Boehner says House must defend the constitution; Jonathan Gruber on center stage about subsidies

Industry Focus eBook - Oncology (1st Edition) eBook

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Newsletters you may be interested in